glutathione brain tumor depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo New therapy for glioma receives
New therapy for glioma receives FDA approval, leveraging cancer research conducted at Johns Hopkins & Duke University Duke OTC Glutamine Imaging: A New Avenue for Glioma Management American Journal of Neuroradiology Frontiers Glutamine's double edged sword: fueling tumor growth and offering therapeutic hope The Microbiome and Cancer David Perlmutter, M.D. What do cancer cells eat? New research reveals surprising fuel source
Pay in 4 interest-free payments of $5.88 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8




